Novavax Covid Vaccine
- All
- News
- Videos
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
-
Novavax Applies For Emergency Use Approval Of Its Covid Vaccine In India
US-based vaccine maker Novavax has filed regulatory submissions for emergency use authorization in India. The submissions were made to the Drugs Controller General of India (DCGI) through its partner, Serum Institute of India (SII), which also manufa
-
European Union Seals Deal With Novavax For Upto 200 Million COVID-19 Vaccines
The European Commission has approved a supply contract with U.S. firm Novavax to buy up to 200 million doses of its potential COVID-19 vaccine, the Commission said on Wednesday.
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
-
Serum Institute's Covovax Covid Vaccine Set For Trials On Children In July: Sources
The Serum Institute of India, which is preparing to produce Novavax's COVID-19 vaccine in the country under the name Covovax, plans to start trials of the vaccine on children next month, the company told NDTV on Thursday.
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
-
Novavax Applies For Emergency Use Approval Of Its Covid Vaccine In India
US-based vaccine maker Novavax has filed regulatory submissions for emergency use authorization in India. The submissions were made to the Drugs Controller General of India (DCGI) through its partner, Serum Institute of India (SII), which also manufa
-
European Union Seals Deal With Novavax For Upto 200 Million COVID-19 Vaccines
The European Commission has approved a supply contract with U.S. firm Novavax to buy up to 200 million doses of its potential COVID-19 vaccine, the Commission said on Wednesday.
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
-
Serum Institute's Covovax Covid Vaccine Set For Trials On Children In July: Sources
The Serum Institute of India, which is preparing to produce Novavax's COVID-19 vaccine in the country under the name Covovax, plans to start trials of the vaccine on children next month, the company told NDTV on Thursday.
